MetaMol aims to develop diagnostics for the ability of cancer to spread and to supplement existing cancer therapies with anti-metastasis drugs.
Company (Alive / Active)
Ohio, United States
|Investor||Investor Type||Location||Participating Rounds|
|San Jose, California, United States||Alive / Active||Canary Foundation was founded in 2004 by Don Listwin, a successful high-technology executive who lost his mother to misdiagnosed ovarian cancer. Don discovered that although almost $10 billion is spent annually on cancer research in the United States, the vast majority is allocated to developing new cancer treatments and caring for patients. Surprisingly, little funding is available to researchers investigating new ways to detect cancer it at its earliest, curable stages. Don made a commitment ...Show all||Login to see details|
|Emeryville, California, United States||Dead / Inactive||Tethys Bioscience is engaged in efforts to create and commercialize blood tests that accurately assess imminent disease risk with an aim of helping physicians preempt the onset of chronic cardiometabolic conditions by focusing healthcare resources on those patients who will benefit the most from early and aggressive intervention. Tethys Bioscience was established in 2005 with initial attention to type 2 diabetes, pursuing the development of an approach designed to transform the way diabetes a...Show all||Login to see details|